1518908455079354368

Today we announced FDA clearance of an IND application for GDA-201, our lead NAM-enabled cell therapy candidate for treatment of patients with follicular and diffuse large B-cell #lymphomas. More: https://t.co/j9iY53Ocav #BloodCancer #HematologicMalignancies #GamidaNKCellTherapy https://t.co/eB5QbKGj9N

Send us a message